Decision Making in a Time of Uncertainty: Dolutegravir for Reproductive-Age Women

Ann Intern Med. 2019 May 7;170(9):658-659. doi: 10.7326/M19-0641. Epub 2019 Apr 2.

Authors

Risa M Hoffman¹, Lynne M Mofenson²

Affiliations

¹ David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California (R.M.H.).
² Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.M.M.).

PMID: 30934065
DOI: 10.7326/M19-0641

No abstract available

Publication types

Editorial
Comment

MeSH terms

Alkynes
Benzoxazines
Cyclopropanes
Decision Making*
Female
HIV Infections*
Heterocyclic Compounds, 3-Ring
Humans
Oxazines
Piperazines
Pyridones
Risk Assessment
Uncertainty

Substances

Alkynes
Benzoxazines
Cyclopropanes
Heterocyclic Compounds, 3-Ring
Oxazines
Piperazines
Pyridones
dolutegravir
efavirenz